Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Cystic Fibrosis Therapeutics Market To Grow At A CAGR Of 31.9% During The Period 2016-2020

Monday, October 17, 2016 2:20
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The primary symptoms of cystic fibrosis include breathing difficulties, high salt content in the sweat, and secretion of abnormally viscous mucus. The principal indicators of cystic fibrosis in patients are pancreatic insufficiency, pancreatitis, chronic bronchitis, adolescent diabetes, male sterility, and very rarely liver cirrhosis or intestinal obstruction. The most usual forms of cystic fibrosis are those with respiratory complications, difficulties related to digestion, and anomalies in height and growth. The mortality and morbidity of a patient are dependent on the degree of bronchopulmonary involvement. 

Publisher’s analysts forecast the global cystic fibrosis therapeutics market to grow at a CAGR of 31.9% during the period 2016-2020.

For more information about this report:         

Covered in this report 
The report covers the present scenario and the growth prospects of the global cystic fibrosis therapeutics market for 2016-2020. The report has taken into consideration the revenue generated by the vendors in the PET packaging market for packaging of different goods.

The market is divided into the following segments based on geography: 

Publisher’s report, Global Cystic Fibrosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
-F. Hoffmann-La Roche
-Gilead Sciences 
-Vertex Pharmaceuticals


Request Sample Copy at        


Other prominent vendors
-Advanced Inhalation Therapies (AIT)
-Alaxia SAS
-Alcresta Therapeutics
-Chiesi Farmaceutici
-Corbus Pharmaceuticals
-Cyclacel Pharmaceuticals
-Digestive Care
-Insmed Incorporated
-Nivalis Therapeutics
-Parion Sciences
-ProQR Therapeutics
-Protalix Biotherapeutics
-Proteostasis Therapeutics
-PTC Therapeutics

Inquire for Report at  


Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.